Citius Pharmaceuticals increases authorized shares 10x, redeems Series A Preferred for $100

Citius Pharmaceuticals, Inc.

Authorized shares increased from 26M to 260M; common shares from 16M to 250M.
Amendment approved at special meeting on June 9, 2025: 547M for, 457M against, 520K abstain.
Series A Preferred (1B votes) automatically redeemed for $100, mirrored votes cast proportionally.
Adjournment proposal became moot after amendment approval.

item 3.03item 5.03item 5.07item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.